BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 14, 2006
View Archived Issues
MGI Submits NDA Seeking FDA Clearance For Saforis
Read More
New Channel Mutations Seen As Neurodegeneration Cause
Read More
Start-Up Cempra Brings Aboard Optimer's Antibacterial Program
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
Gilead Invests $25M In Corus While Retaining Buyout Option
Gilead Sciences Inc. is putting $25 million into Corus Pharma Inc., and has an option to buy the rest of the respiratory disease-focused firm down the road. (BioWorld Today)
Read More